Literature DB >> 25428668

Progress on diabetic cerebrovascular diseases.

Houguang Zhou1, Xiaoming Zhang, Jianfeng Lu.   

Abstract

Diabetic cerebrovascular diseases are defined as cerebral vascular diseases induced by diabetes with sugar, fat and a series of nutrient substance metabolic disorders, resulting in intracranial large and small vessel diseases. About 20%-40% patients with type 2 diabetes suffer from cerebral blood vessel diseases. Diabetic cerebrovascular diseases are the main causes of death in patients with diabetes mellitus. The major clinical manifestations are asymptomatic cerebral atherosclerosis, stroke, cerebral small vessel disease and acute cerebral vascular disease. The pathogenesis, clinical characteristics, treatment and prognosis of diabetic cerebrovascular disease are obviously different from non-diabetic cerebral vascular diseases. This paper will focus on the diabetic cerebrovascular disease, including its latest research progress. Diabetic cerebral large vascular disease and diabetic cerebral small vessel disease will be reviewed here.

Entities:  

Mesh:

Year:  2014        PMID: 25428668      PMCID: PMC4333964          DOI: 10.17305/bjbms.2014.4.203

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  41 in total

1.  J-shaped association between serum glucose and functional outcome in acute ischemic stroke.

Authors:  George Ntaios; Marc Egli; Mohamed Faouzi; Patrik Michel
Journal:  Stroke       Date:  2010-08-19       Impact factor: 7.914

2.  Vascular oxidative stress increases dendritic cell adhesion and transmigration induced by homocysteine.

Authors:  Wei-Guo Zhu; Shan Li; Le-Qing Lin; Hui Yan; Ting Fu; Jian-Hua Zhu
Journal:  Cell Immunol       Date:  2008-09-21       Impact factor: 4.868

3.  Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators.

Authors:  A Bruno; J Biller; H P Adams; W R Clarke; R F Woolson; L S Williams; M D Hansen
Journal:  Neurology       Date:  1999-01-15       Impact factor: 9.910

4.  Duration of diabetes and risk of ischemic stroke: the Northern Manhattan Study.

Authors:  Chirantan Banerjee; Yeseon P Moon; Myunghee C Paik; Tatjana Rundek; Consuelo Mora-McLaughlin; Julio R Vieira; Ralph L Sacco; Mitchell S V Elkind
Journal:  Stroke       Date:  2012-03-01       Impact factor: 7.914

5.  Increased matrix metalloproteinase-9 activity in unstable carotid plaques. A potential role in acute plaque disruption.

Authors:  I M Loftus; A R Naylor; S Goodall; M Crowther; L Jones; P R Bell; M M Thompson
Journal:  Stroke       Date:  2000-01       Impact factor: 7.914

6.  Deficits in human trisomy 21 iPSCs and neurons.

Authors:  Jason P Weick; Dustie L Held; George F Bonadurer; Matthew E Doers; Yan Liu; Chelsie Maguire; Aaron Clark; Joshua A Knackert; Katharine Molinarolo; Michael Musser; Lin Yao; Yingnan Yin; Jianfeng Lu; Xiaoqing Zhang; Su-Chun Zhang; Anita Bhattacharyya
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-28       Impact factor: 11.205

7.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

8.  Modeling ALS with iPSCs reveals that mutant SOD1 misregulates neurofilament balance in motor neurons.

Authors:  Hong Chen; Kun Qian; Zhongwei Du; Jingyuan Cao; Andrew Petersen; Huisheng Liu; Lisle W Blackbourn; CindyTzu-Ling Huang; Anthony Errigo; Yingnan Yin; Jianfeng Lu; Melvin Ayala; Su-Chun Zhang
Journal:  Cell Stem Cell       Date:  2014-04-03       Impact factor: 24.633

9.  Time-dependent impact of diabetes on mortality in patients with stroke: survival up to 5 years in a health insurance population cohort in Germany.

Authors:  Andrea Icks; Heiner Claessen; Stephan Morbach; Gerd Glaeske; Falk Hoffmann
Journal:  Diabetes Care       Date:  2012-06-11       Impact factor: 19.112

10.  Glucagon-like peptide-1 receptor activation reduces ischaemic brain damage following stroke in Type 2 diabetic rats.

Authors:  Vladimer Darsalia; Shiva Mansouri; Henrik Ortsäter; Anna Olverling; Nino Nozadze; Camilla Kappe; Kerstin Iverfeldt; Linda M Tracy; Nina Grankvist; Åke Sjöholm; Cesare Patrone
Journal:  Clin Sci (Lond)       Date:  2012-05-01       Impact factor: 6.124

View more
  17 in total

1.  Impact of elastin-derived VGVAPG peptide on bidirectional interaction between peroxisome proliferator-activated receptor gamma (Pparγ) and beta-galactosidase (β-Gal) expression in mouse cortical astrocytes in vitro.

Authors:  Konrad A Szychowski; Jan Gmiński
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-12-03       Impact factor: 3.000

2.  Accelerated cerebral vascular injury in diabetes is associated with vascular smooth muscle cell dysfunction.

Authors:  Ya Guo; Shaoxun Wang; Yedan Liu; Letao Fan; George W Booz; Richard J Roman; Zongbo Chen; Fan Fan
Journal:  Geroscience       Date:  2020-03-12       Impact factor: 7.713

Review 3.  Neurovascular Coupling in Type 2 Diabetes With Cognitive Decline. A Narrative Review of Neuroimaging Findings and Their Pathophysiological Implications.

Authors:  Mads C J Barloese; Christian Bauer; Esben Thade Petersen; Christian Stevns Hansen; Sten Madsbad; Hartwig Roman Siebner
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-04       Impact factor: 6.055

Review 4.  Implementation of Imaging Methods in Evaluation of T2DM-Correlated Brain Alterations and Cognitive Dysfunction.

Authors:  Marianna Karvani; Dorothea Kapoukranidou
Journal:  Acta Inform Med       Date:  2020-06

5.  The resting perfusion pattern associates with functional decline in type 2 diabetes.

Authors:  Weiying Dai; Wenna Duan; Freddy J Alfaro; Anna Gavrieli; Fotini Kourtelidis; Vera Novak
Journal:  Neurobiol Aging       Date:  2017-09-14       Impact factor: 4.673

6.  Reduced pericyte and tight junction coverage in old diabetic rats are associated with hyperglycemia-induced cerebrovascular pericyte dysfunction.

Authors:  Yedan Liu; Huawei Zhang; Shaoxun Wang; Ya Guo; Xing Fang; Baoying Zheng; Wenjun Gao; Hongwei Yu; Zongbo Chen; Richard J Roman; Fan Fan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-12-11       Impact factor: 4.733

7.  Identifying Patterns of Lifestyle Behaviors among People with Type 2 Diabetes in Tianjin, China: A Latent Class Analysis.

Authors:  Xuying Wang; Jiageng Chen; Xiaoqian Liu; Fei Gao; Haozuo Zhao; Duolan Han; Xiyue Jing; Yuanyuan Liu; Zhuang Cui; Changping Li; Jun Ma
Journal:  Diabetes Ther       Date:  2017-11-01       Impact factor: 2.945

8.  Risk factors associated with outcomes of peritoneal dialysis in Taiwan: An analysis using a competing risk model.

Authors:  Hsiao-Ling Chen; Der-Cherng Tarng; Lian-Hua Huang
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

9.  Acute Resveratrol Consumption Improves Neurovascular Coupling Capacity in Adults with Type 2 Diabetes Mellitus.

Authors:  Rachel H X Wong; Daniel Raederstorff; Peter R C Howe
Journal:  Nutrients       Date:  2016-07-12       Impact factor: 5.717

10.  Reduced Regional Cerebral Blood Flow Relates to Poorer Cognition in Older Adults With Type 2 Diabetes.

Authors:  Katherine J Bangen; Madeleine L Werhane; Alexandra J Weigand; Emily C Edmonds; Lisa Delano-Wood; Kelsey R Thomas; Daniel A Nation; Nicole D Evangelista; Alexandra L Clark; Thomas T Liu; Mark W Bondi
Journal:  Front Aging Neurosci       Date:  2018-09-10       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.